Frontier Medicines | ApexOnco - Clinical Trials news and analysis

x

“It's very intuitive and always up-to-date”

Monika Vogelmann

Head of Market Insights Oncology Europe

Daiichi Sankyo

Click here for more information

Trial results

8 February 2024

KRAS and conjugates remain hot

The latest clinical study listings reveal KRAS-targeting projects, ADCs and others starting phase 1.

Subscribe to Frontier Medicines